TNF Pharmaceuticals, Inc. (TNFA)
NASDAQ: TNFA · Real-Time Price · USD
0.3513
-0.0087 (-2.42%)
Mar 31, 2025, 3:54 PM EDT - Market open
TNF Pharmaceuticals Market Cap
TNF Pharmaceuticals has a market cap or net worth of $967.86 thousand as of March 31, 2025. Its market cap has decreased by -82.40% in one year.
Market Cap
967.86K
Enterprise Value
-9.63M
1-Year Change
-82.40%
Ranking
Category
Stock Price
0.35
Market Cap Chart
Since January 24, 2014, TNF Pharmaceuticals's market cap has decreased from $25.90M to $967.86K, a decrease of -96.26%. That is a compound annual growth rate of -25.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 1.00M | -68.75% |
| Dec 31, 2024 | 3.20M | -75.76% |
| Dec 29, 2023 | 13.20M | -70.93% |
| Dec 30, 2022 | 45.40M | -80.10% |
| Dec 31, 2021 | 228.10M | 1,196.02% |
| Dec 31, 2020 | 17.60M | 935.29% |
| Dec 31, 2019 | 1.70M | -87.94% |
| Dec 31, 2018 | 14.10M | 984.62% |
| Dec 29, 2017 | 1.30M | -87.50% |
| Dec 30, 2016 | 10.40M | 67.74% |
| Dec 31, 2015 | 6.20M | -68.69% |
| Dec 31, 2014 | 19.80M | -23.55% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |